How much has Abnormal Security raised?

Abnormal AI has raised $546M in equity capital across four formal venture rounds: a $24M Series A in November 2019, a $50M Series B in November 2020, a $210M Series C in May 2022, and a $250M Series D in August 2024. No public debt, convertible notes, or secondary transactions have been disclosed, making this an all-equity story.

The pace of fundraising is striking: $24M to $546M in five years, with each round tracking an ARR doubling or better. The Series A launched the product publicly; the Series B validated go-to-market traction with Fortune 500 customers; the Series C awarded unicorn status at $4B; and the Series D at $5.1B confirmed that Abnormal is tracking toward a public offering on the strength of its ARR and retention metrics.

As of June 2026, Abnormal remains private. Private market secondary platforms (Nasdaq Private Market, EquityZen, Forge Global) have estimated implied share prices in the $19–$21 range, suggesting a total equity valuation modestly above the $5.1B Series D figure on strong ARR momentum.

Greylock Partners was the first institutional backer, leading the $24M Series A. Greylock partner Asheem Chandna championed the deal after Reiser and Jeyakumar conducted 50+ interviews with Fortune 500 CIOs and CISOs — a diligence-first approach that impressed Greylock enough to back the company at an early stage. Greylock has participated in every subsequent round, making it the longest-standing and most consistent insider.

Menlo Ventures led the Series B and remained a follow-on investor through the Series D. Insight Partners led the $210M Series C in May 2022, bringing its operational ScaleUp network to help Abnormal accelerate enterprise go-to-market in North America and Europe. Insight's track record in high-growth enterprise SaaS companies made it a natural lead for a growth-stage round in a buoyant 2022 market.

Wellington Management, the $1T+ Boston-based asset manager known for backing late-stage growth companies pre-IPO (it backed companies like Airbnb and Stripe before their public offerings), led the Series D. This is a clear signal of institutional crossover confidence ahead of a potential public offering. The CrowdStrike Falcon Fund's participation adds a strategic-ecosystem dimension: it validates Abnormal as a partner-safe investment within the broader CrowdStrike platform, not a competitive threat, and opens co-sell avenues.

The Series C in May 2022 closed at $4B just as public-market SaaS multiples began to collapse. Many high-growth SaaS companies that raised at peak 2021 valuations faced flat or down rounds in 2023–2024. Abnormal's Series D at $5.1B (a 27.5% step-up over more than two years) reflects disciplined valuation calibration rather than a down-round: the company's business fundamentals improved dramatically — ARR roughly doubled from ~$100M to >$200M — while multiples in the sector compressed from 40–50x to 15–25x ARR.

At $5.1B on $200M+ ARR, Abnormal priced the Series D at roughly 25x ARR, a healthy premium to the public email-security peer group (Proofpoint trades at ~6x ARR post-LBO) but well below the 40–50x peaks of 2021. This positions the company well for an eventual IPO without requiring an aggressive step-up from public investors who may be buying in at a modest premium to the last private round.

No down-round has occurred at any stage in Abnormal's funding history. The company has maintained consistent upward valuation progression across all four rounds, even navigating the 2022–2024 SaaS correction with only a moderate multiple compression.

Abnormal has not publicly disclosed profitability, EBITDA, or operating margins. However, CEO Evan Reiser explicitly discussed IPO ambitions following the Series D, targeting readiness to "operate as a public company" as early as Q4 2025. Analysts tracking the company view a 2026 public filing as the most likely scenario, contingent on sustained ARR growth above 40% year-over-year and favorable public market conditions for cybersecurity names.

The January 2025 CFO appointment of Lisa Banks — previously SVP Finance at ServiceNow, a company with deep experience operating at scale in the public markets — is the clearest organizational indicator of active IPO preparation. Banks was hired explicitly to build the financial infrastructure for a $1B+ ARR company and a public listing. The appointment of Chief Legal Officer Jeff True (March 2024) rounds out the governance structure needed for Sarbanes-Oxley readiness.

Wellington Management's participation in the Series D also fits the pattern of crossover investors who bridge private and public capital markets, often anchoring the institutional book in an IPO. Nasdaq Private Market and EquityZen secondary trading at $19–$21 per share implies liquidity and price discovery ahead of a formal public offering. As of June 2026, no IPO filing has been made public.

A $546M-funded company at $5.1B valuation with $200M+ ARR is a sophisticated enterprise buyer with well-established procurement infrastructure. Abnormal has dedicated finance, legal, and vendor management functions; deals over $50K typically require security reviews, MSAs, and multi-stakeholder sign-off. Expect a 60–120 day sales cycle for net-new enterprise software categories.

The Series D in particular unlocked new budget categories: the $250M raise was earmarked for international expansion (Europe, Germany, Japan, France), product R&D, and go-to-market headcount growth. Vendors who sell sales intelligence, HR tech, developer tooling, cloud infrastructure, or professional services into fast-scaling global security companies will find Abnormal's buying committees active and funded. The FedRAMP Moderate Authorization achieved in April 2025 also signals active investment in compliance infrastructure — an area where security, legal, and engineering all converge as buyers.

The CrowdStrike Falcon Fund's involvement further suggests that Abnormal leans into the broader CrowdStrike platform ecosystem. Technology partners native to that stack — or who can demonstrate Falcon platform integration — face lower friction in Abnormal's vendor evaluations. Timing is also favorable: as the company prepares for an IPO, it is actively investing in the tools and infrastructure needed to operate as a public company, creating budget cycles for finance tech, investor relations platforms, and enterprise GRC tooling.